(Q27692554)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22235870%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22235870%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22235870%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1

Jeanette M Tetrault

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22235870%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22235870%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22235870%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

72

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22235870%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22235870%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

217-228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22235870%20AND%20SRC:MED&resulttype=core&format=json

Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence

20 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Oral naltrexone maintenance treatment for opioid dependence

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Heroin maintenance for chronic heroin-dependent individuals

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Sustained-Release Naltrexone For Opioid Dependence

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Drug treatment as HIV prevention: a research update

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Long-acting depot formulations of naltrexone for heroin dependence: a review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

The pharmacological treatment of opioid addiction--a clinical perspective

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Home- versus office-based buprenorphine inductions for opioid-dependent patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Levo-alpha-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

QTc interval screening in methadone treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Hypogonadism in men receiving methadone and buprenorphine maintenance treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Interaction between buprenorphine and atazanavir or atazanavir/ritonavir.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Opioid dependence: rationale for and efficacy of existing and new treatments

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Low bone density in patients receiving methadone maintenance treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Management of drug and alcohol withdrawal

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Regulation of neural gene expression in opiate and cocaine addiction.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Successful treatment of 750 criminal addicts

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Implications of methadone maintenance for theories of narcotic addiction

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Six deaths linked to concomitant use of buprenorphine and benzodiazepines

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Molecular mechanisms of opiate and cocaine addiction

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Pharmacotherapy for opioid and cocaine abuse

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

The effects of psychosocial services in substance abuse treatment.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Naltrexone treatment for addicted health-care professionals: a collaborative private practice experience.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Narcotic Addiction, Physical Dependence and Relapse

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Naltrexone treatment--the problem of patient acceptance

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

A controlled trial of buprenorphine treatment for opioid dependence

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

New federal initiatives to enhance the medical treatment of opioid dependence

2 June 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Methods of detoxification and their role in treating patients with opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Dose-response effects of methadone in the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Alternate-day dosing during buprenorphine treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Comparison of buprenorphine and methadone in the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Elevated liver enzyme levels in opioid-dependent patients with hepatitis treated with buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Case series on the safe use of buprenorphine/naloxone in individuals with acute hepatitis C infection and abnormal hepatic liver transaminases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Retention in naltrexone implant treatment for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Buprenorphine treatment of opioid dependence: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Strategies to Improve Compliance with Narcotic Antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597520-000000000-00000

Outpatient non-opioid detoxification for opioid withdrawal. Who is likely to benefit?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Can psychotherapy rescue naltrexone treatment of opioid addiction?

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701303

Influence of concomitant drugs on methadone elimination half-life in patients under a maintenance treatment

27 November 2018

1 reference

12 December 2020

1 reference

12 December 2020

First do no harm ... Reduction?

1 reference

12 December 2020

The role of Cochrane reviews in informing international guidelines: a case study of using the Grading of Recommendations, Assessment, Development and Evaluation system to develop World Health Organization guidelines for the psychosocially assisted p

1 reference

12 December 2020

Naltrexone: a clinical perspective

1 reference

12 December 2020

10.2165/11597520-000000000-00000

Identifiers

DOI

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22235870%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 January 2020

0 references

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22235870%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

2 references